Profile picture

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
Membership: FESC Member
Follow
Biography
P. Gabriel Steg, MD, FESC, FACC Born Feb 16, 1959 Université Paris-Cité, INSERM U-1148, Département de Cardiologie, Hôpital Bichat Assistance Publique - Hôpitaux de Paris 46, rue Henri Huchard, 75877 Paris cedex 18, France Phone: +33 1 40 25 86 68, Fax : +33 1 40 25 88 65 E-mail: gabriel.steg@aphp.fr Affiliations - Chief, Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, in Paris, France. - Vice President (in charge of research) of the board of Assistance Publique-Hôpitaux de Paris since 2018. - Professor of Cardiology at Université Paris - Cité (since 1994). - Senior Professor, Institut Universitaire de France (Innovation Chair) - Director of the “Clinical Research in Atherothrombosis” Research Team, INSERM Unit U1148, Paris - Coordinator of the iVASC (InnoVations in Atherothrombosis SCience) RHU research consortium. - Chair of the FACT (French Alliance for cardiovascular Clinical Trials) academic research network
Logo ESC

Contributor content

Clinical scenarios addressing residual risk in atherosclerotic cardiovascular disease (ASCVD): understanding the role of triglycerides and eicosapentaenoic acid (EPA)
Session
Clinical scenarios addressing residual risk in atherosclerotic cardiovascular disease (ASCVD): understanding the role of triglycerides and eicosapentaenoic acid (EPA)
31 August 2024
Revascularisation dilemmas in chronic coronary syndromes
Session
Revascularisation dilemmas in chronic coronary syndromes
27 August 2023
Fine-tuning post-acute coronary syndrome cardio protection: the case for early and aggressive lipid-lowering
Session
Fine-tuning post-acute coronary syndrome cardio protection: the case for early and aggressive lipid-lowering
26 August 2023
HOT LINE SESSION 9
Session
HOT LINE SESSION 9
29 August 2022
Lipid lowering and antiplatelet strategies post- acute coronary syndromes (ACS): a case-based discussion
Session
Lipid lowering and antiplatelet strategies post- acute coronary syndromes (ACS): a case-based discussion
26 August 2022
Late Breaking Trials in ACS
Session
Late Breaking Trials in ACS
27 August 2021
Clinical Update on Managing Hypertriglyceridaemia  with Omega-3 Fatty Acid Icosapent Ethyl
Session
Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl
31 August 2020
Hot Line Session 6
Session
Hot Line Session 6
3 September 2019
Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)
Session
Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)
3 September 2019
Cardiovascular drugs in acute coronary syndromes: when to start and when to stop
Session
Cardiovascular drugs in acute coronary syndromes: when to start and when to stop
2 September 2019

ESC 365 is supported by